Huperzine A/Huperzia serrata / PKA Cancer Research Results

Hup, Huperzine A/Huperzia serrata: Click to Expand ⟱
Features:
huperzine A is a natural product and has been studied for its potential benefits in Alzheimer's disease (AD).
-inhibits acetylcholinesterase(AChE), the enzyme that breaks down acetylcholine, a key neurotransmitter involved in memory and learning.

Huperzine A (Huperzia serrata) – Alzheimer's Disease (AD) Pathway Matrix

Rank Pathway / Axis AD Direction Mechanism Snapshot TSF Evidence Notes / Clinical Relevance
1 AChE Inhibition ACh ↑ Potent reversible acetylcholinesterase inhibitor → increases synaptic acetylcholine P, R Human trials (moderate) Primary mechanism; similar functional class to donepezil. Improves memory and cognition scores in mild–moderate AD.
2 NMDA Receptor Modulation Excitotoxicity ↓ Partial antagonistic modulation of NMDA receptor signaling R Preclinical + supportive Reduces glutamate-mediated excitotoxicity; complementary to cholinergic effects.
3 Mitochondrial Protection Mito dysfunction ↓ Preserves mitochondrial membrane potential; reduces cytochrome c release R, G Preclinical Supports neuronal survival under oxidative stress conditions.
4 ROS Modulation ROS ↓ (neuronal models) Reduces oxidative stress markers; improves antioxidant enzyme activity R, G Preclinical Neuroprotective antioxidant effect; contrasts with pro-oxidant effect in some cancer cells.
5 Aβ Toxicity Modulation Aβ neurotoxicity ↓ Reduces Aβ-induced neuronal apoptosis G Preclinical Protects against Aβ-mediated mitochondrial and synaptic injury.
6 Tau Pathology p-tau ↓ (model data) Indirect reduction of hyperphosphorylated tau via neuroprotective signaling G Limited preclinical Not a primary anti-tau agent but supportive.
7 BDNF Support BDNF ↑ (indirect) Enhances synaptic plasticity signaling G Preclinical Supports cognitive resilience.
8 Neuroinflammation IL-1β ↓, TNF-α ↓ (model data) Reduces pro-inflammatory cytokines in brain models G Preclinical Anti-inflammatory contribution secondary to cholinergic signaling.

Time-Scale Flag (TSF):
P = 0–30 min (enzyme inhibition)
R = 30 min–3 hr (neurotransmission / mitochondrial signaling shifts)
G = >3 hr (synaptic plasticity, inflammation modulation, neuroprotection)
PKA, protein kinase A: Click to Expand ⟱
Source:
Type:
Protein kinase A (PKA)
• PKA is composed of regulatory (R) and catalytic (C) subunits. Binding of cAMP to the regulatory subunits releases the catalytic subunits, which then phosphorylate target proteins.
– Increased PKA activity has been associated with the activation of downstream signaling pathways that promote cell growth and survival.
– Thus, the level of PKA activation (often indirectly inferred by phosphorylation status of downstream targets) can serve as a marker for tumor progression and treatment resistance.
– PKA does not act in isolation—it interacts with other signaling pathways (e.g., MAPK, PI3K/AKT).
Scientific Papers found: Click to Expand⟱
4213- Hup,    Huperzine A-Liposomes Efficiently Improve Neural Injury in the Hippocampus of Mice with Chronic Intermittent Hypoxia
- in-vivo, NA, NA
*cognitive↑, *SOD↑, *GPx↑, *MDA↓, *ROS↓, *Iron↓, *TfR1/CD71↓, *FTL↓, *ERK↑, *PKA↑, *CREB↑, *BDNF↑, *PSD95↑, *neuroP↑,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Total Targets: 0

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress ⓘ

GPx↑, 1,   Iron↓, 1,   MDA↓, 1,   ROS↓, 1,   SOD↑, 1,  

Metal & Cofactor Biology ⓘ

FTL↓, 1,   TfR1/CD71↓, 1,  

Core Metabolism/Glycolysis ⓘ

CREB↑, 1,  

Proliferation, Differentiation & Cell State ⓘ

ERK↑, 1,  

Migration ⓘ

PKA↑, 1,  

Synaptic & Neurotransmission ⓘ

BDNF↑, 1,   PSD95↑, 1,  

Functional Outcomes ⓘ

cognitive↑, 1,   neuroP↑, 1,  
Total Targets: 14

Scientific Paper Hit Count for: PKA, protein kinase A
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:343  Target#:1194  State#:%  Dir#:2
  wNotes=0  sortOrder:rid,rpid

 

Home Page